AllCells – Caltag Medsystems

How AllCells’ Expanded Donor Collection Facilities Help You to Recruit the Right Donors and Scale Your Cell and Gene Therapy Development

AllCells’ has thousands of well-characterised, highly engaged recallable donors, with specific attributes, at collection sites across the US & Europe.

Overcoming the Donor Selection Challenges to Drive Success in Cell and Gene Therapy Development and Commercialisation

AllCells’ Pre-Characterised Donor Selection Program expedites screening, selecting & collecting from donors for downstream clinical manufacturing.

Reframing the Inherent Donor Supply Chain Ecosystem to Support the Imminent CGT Manufacturing Boom: Recap of the Allogeneic Cell Therapies Summit 2023

Key takeaways from AllCells’ VP of Donor Operations presentation on reframing the donor supply chain ecosystem to support the CGT manufacturing boom.

The World’s Largest Apheresis Network Serves as a Catalyst to Advance Cell and Gene Therapies

AllCells and Discovery continue to expand their solutions alongside the CGT industry to help researchers overcome roadblocks.